| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |